Team:UC Santa Barbara/Project
From 2014.igem.org
Line 91: | Line 91: | ||
<tr> <td colspan="3"> | <tr> <td colspan="3"> | ||
<h3> Our story </h3> | <h3> Our story </h3> | ||
- | <p> We started off as a team of three, With John, Travis, and Sarah forming a team with Dan. Soon, that team grew in number and the initiative to form the first UCSB iGEM team started gaining momentum. Fundraising was tricky, as it usually is, but money was eventually found through small corporate sponsorship and a rather large bake sale. Dr. Chris Hayes was nice enough to let us use part of his lab for our project, and one of his graduate students, Christina Beck, agreed to mentor us. Dr. David low green-lit our project and gave us background knowledge and access to his strain collection in order to facilitate our project. | + | <p> We started off as a team of three, With John, Travis, and Sarah forming a team with Dan.Dr. Omar Saleh, Dan's PI, graciously agreed to sponsor our program, marking the beginning of the UCSB iGEM Team. Soon, that team grew in number and the initiative to form the first UCSB iGEM team started gaining momentum. Fundraising was tricky, as it usually is, but money was eventually found through small corporate sponsorship and a rather large bake sale. Dr. Chris Hayes was nice enough to let us use part of his lab for our project, and one of his graduate students, Christina Beck, agreed to mentor us. Dr. David low green-lit our project and gave us background knowledge and access to his strain collection in order to facilitate our project. |
<br> | <br> | ||
<br> | <br> |
Revision as of 02:34, 18 October 2014
| |||||||||||||
Project Description |
|||||||||||||
Team UC Santa Barbara's project goal is to engineer a strain of E. coli that expresses GFP in response to contact with a different strain of bacteria.. The proposed mechanism of action is an application of contact-dependent growth inhibition (CDI). CDI is a system used by some bacteria to inhibit other bacterial cells that are in direct contact 1. Particularly, cells that do not have the proper immunity protein will be inhibited. In applying CDI to fit the project goal, we are engineering two strains of E. coli: an "attacker" strain and an "indicator" strain. The attacker strain is engineered to express the CdiA-CTUPEC536 C-terminal toxin fused to CdiAEC93. The purpose of this is to emulate the presence of uropathogenic E. coli 536 (UPEC536) strain cells without requiring BSL-2 handling procedures (under CDI, this strain ideally functions identically to UPEC536). In order for the indicator strain to express fluorescent protein and withstand CdiA-CTUPEC536, it expresses the following constructs: CysK-T25 (a permissive factor required for binding CdiA-CTUPEC536 fused to a fragment of adenylate cyclase), T18-CdiIUPEC536 (a complementary fragment of adenylate cycle fused to the immunity protein corresponding to CdiA-CTUPEC536), and GFP under the pap promoter, which is cAMP-dependent, similar to the lac promoter. Once CdiA-CTUPEC536 is inserted into an indicator cell, it binds to CysK and CdiI, bringing T25 and T18 in close proximity to function as an adenylate cyclase unit (principally based on the bacterial adenylate cyclase two-hybrid system (BACTH)). cAMP is thereby produced, inducing the expression of GFP via the pap promoter. Notably, the indicator strain is cyaAΔ so that cAMP production is only caused by the joining of T25 and T18. |
|||||||||||||
References1 Ruhe ZC, Low DA, Hayes CS. Bacterial contact-dependent growth inhibition. Trends in Microbiol. 2013 May;21(5):230-7. |
|||||||||||||
Our story We started off as a team of three, With John, Travis, and Sarah forming a team with Dan.Dr. Omar Saleh, Dan's PI, graciously agreed to sponsor our program, marking the beginning of the UCSB iGEM Team. Soon, that team grew in number and the initiative to form the first UCSB iGEM team started gaining momentum. Fundraising was tricky, as it usually is, but money was eventually found through small corporate sponsorship and a rather large bake sale. Dr. Chris Hayes was nice enough to let us use part of his lab for our project, and one of his graduate students, Christina Beck, agreed to mentor us. Dr. David low green-lit our project and gave us background knowledge and access to his strain collection in order to facilitate our project.
|